Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

QuidelOrtho Corporation Common Stock (QDEL)

In Vitro & In Vivo Diagnostic Substances

https://www.quidelortho.com

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make better decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

9975 SUMMERS RIDGE ROAD
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/03/1992

Market Cap

2,988,613,530

Shares Outstanding

66,819,999

Weighted SO

66,818,718

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

TNDM --.--%

DXCM --.--%

INSP --.--%

SWAV --.--%

PEN --.--%

NUVA --.--%

GKOS --.--%

CNMD --.--%

LIVN --.--%

Beta

0.0670

Last Div

0.0000

Range

29.74-84.6

Chg

-0.2000

Avg Vol

1203138

Mkt Cap

2988613530

Exch

NASDAQ

Country

US

Phone

858 552 1100

DCF Diff

21.0447

DCF

107.3550

Div Yield

0.0000

P/S

1.0551

EV Multiple

16.2988

P/FV

0.9398

Div Yield %

0.0000

P/E

-1.6041

PEG

-0.6223

Payout

-0.0070

Current Ratio

1.4385

Quick Ratio

0.7929

Cash Ratio

0.1148

DSO

64.0805

DIO

133.7208

Op Cycle

197.8013

DPO

52.7331

CCC

145.0682

Gross Margin

0.4199

Op Margin

0.0148

Pretax Margin

-0.7013

Net Margin

-0.6564

Eff Tax Rate

0.0640

ROA

-0.2780

ROE

-0.4520

ROCE

0.0073

NI/EBT

0.9360

EBT/EBIT

-47.2976

EBIT/Rev

0.0148

Debt Ratio

0.3876

D/E

0.8171

LT Debt/Cap

0.4102

Total Debt/Cap

0.4497

Int Coverage

0.2597

CF/Debt

0.0090

Equity Multi

2.1078

Rec Turnover

5.6960

Pay Turnover

6.9217

Inv Turnover

2.7296

FA Turnover

1.8835

Asset Turnover

0.4235

OCF/Share

0.3472

FCF/Share

-2.5350

Cash/Share

1.5946

OCF/Sales

0.0082

FCF/OCF

-7.3004

CF Coverage

0.0090

ST Coverage

0.0604

CapEx Coverage

0.1205

Div&CapEx Cov

0.1129

P/BV

0.9398

P/B

0.9398

P/S

1.0551

P/E

-1.6041

P/FCF

-17.5697

P/OCF

128.0084

P/CF

128.0084

PEG

-0.6223

P/S

1.0551

EV Multiple

16.2988

P/FV

0.9398

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 20, 13:52 This stock-fund manager outperforms with ‘fixer-uppers’ MarketWatch Jan 16, 13:45 This stock fund manager outperforms with ‘fixer-uppers’

Revenue Product Segmentation